title: Biomarkers in community-acquired pneumonia: a state-of-the-art review.
abstract: Community-acquired pneumonia (CAP) exhibits mortality rates, between 20% and 50% in severe cases. Biomarkers are useful tools for searching for antibiotic therapy modifications and for CAP diagnosis, prognosis and follow-up treatment. This non-systematic state-of-the-art review presents the biological and clinical features of biomarkers in CAP patients, including procalcitonin, C-reactive protein, copeptin, pro-ANP (atrial natriuretic peptide), adrenomedullin, cortisol and D-dimers.
authors.affiliation: Faculdade de Medicina da Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Departamento de Medicina Interna, Porto Alegre/RS, Brazil. reseligman@hcpa.ufrgs.br
authors.forename: Renato
authors.initials: R
authors.lastname: Seligman
authors.forename: Luis Francisco
authors.initials: LF
authors.lastname: Ramos-Lima
authors.forename: Vivian do Amaral
authors.initials: Vdo A
authors.lastname: Oliveira
authors.forename: Carina
authors.initials: C
authors.lastname: Sanvicente
authors.forename: Elyara F
authors.initials: EF
authors.lastname: Pacheco
authors.forename: Karoline
authors.initials: K
authors.lastname: Dalla Rosa
mesh_terms: D015415:Biomarkers / Q000032:analysis*; D017714:Community-Acquired Infections / Q000175:diagnosis; D006801:Humans; D011014:Pneumonia / Q000175:diagnosis*
chemical_list: D015415:Biomarkers